biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by frohlir944on Aug 17, 2017 3:54pm

131 Views

Post# 26593525

RE:looks like 100k+

Lets add a little to the tought. Mark and others have been touring the North America, Europe and Asia giving presentations to pharma companies, their Execs, and highly compensated employees (lets assume they are smart as well and knew to wait until the free trading shares were in play thus assuming a bottom). All those people plus others probably (Cathrine London in her new possition may be talking to investors, funds, hedge managers etc) All those people were waiting for a bottom to start accumulating.

Great things can now unfold!

Bullboard Posts

The top 10 Canadian medical stocks